The DPP-4 inhibitor sitagliptin improves glycaemic control and early-stage diabetic nephropathy in adolescents with type 1 diabetes using the MiniMed 780G advanced hybrid closed-loop system: a randomised controlled trial

2024-9-14

Risk factors for Charcot foot development in individuals with diabetes mellitus

2024-9-13

Up Front

2024-9-13

Genetic evidence for efficacy of targeting IL-2, IL-6 and TYK2 signalling in the prevention of type 1 diabetes: a Mendelian randomisation study

2024-9-13

Metabolic health in people living with type 1 diabetes in Belgium: a repeated cross-sectional study

2024-9-13

60th EASD Annual Meeting of the European Association for the Study of Diabetes

2024-9-12

Correction: Diabetes technology in people with diabetes and advanced chronic kidney disease

2024-9-10

An antifibrotic compound that ameliorates hyperglycaemia and fat accumulation in cell and HFD mouse models

2024-9-9

The islet tissue plasminogen activator/plasmin system is upregulated with human islet amyloid polypeptide aggregation and protects beta cells from aggregation-induced toxicity

2024-9-9

Comment on the role of interferons in the pathology of beta cell destruction in type 1 diabetes

2024-9-7

Implicating type 2 diabetes effector genes in relevant metabolic cellular models using promoter-focused Capture-C

2024-9-6

Lifetime history of gestational diabetes and cognitive function in parous women in midlife

2024-9-6

Comment on the role of interferons in the pathology of beta cell destruction in type 1 diabetes. Reply to Lenzen S [letter]

2024-9-5

Similar early metabolic changes induced by dietary weight loss or bariatric surgery

2024-9-5

Similar early metabolic changes induced by dietary weight loss or bariatric surgery. Reply to Taylor R [letter]

2024-9-5

Correction to: Consensus guidance for monitoring individuals with islet autoantibody‑positive pre‑stage 3 type 1 diabetes

2024-9-4

Dietary patterns during pregnancy and maternal and birth outcomes in women with type 1 diabetes: the Environmental Determinants of Islet Autoimmunity (ENDIA) study

2024-9-2

Metformin and small for gestational age babies: findings of a randomised placebo-controlled clinical trial of metformin in gestational diabetes (EMERGE)

2024-8-31

Global experiences and personal narratives on diabetes technology and access

2024-8-30

The future is here: an overview of technology in diabetes

2024-8-30

Effects of sodium–glucose cotransporter 2 inhibitors on cardiovascular and renal outcomes in people with diabetes and advanced chronic kidney disease

2024-8-29

Genetics of glucose homeostasis in pregnancy and postpartum

2024-8-24

Novel secreted regulators of glucose and lipid metabolism in the development of metabolic diseases

2024-8-24

Comparative renal outcomes of matched cohorts of patients with type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists under routine care

2024-8-23

Machine learning-based reproducible prediction of type 2 diabetes subtypes

2024-8-21

Glycaemic control is still central in the hierarchy of priorities in type 2 diabetes management

2024-8-19

Reduced type 2 diabetes incidence reflecting end of post‑World War II calorie restrictions in Germany. Reply to Nilsson PM, Vaag A [letter]

2024-8-17

Applying technologies to simplify strategies for exercise in type 1 diabetes

2024-8-15

Reduced type 2 diabetes incidence reflecting end of post-World War II calorie restrictions in Germany

2024-8-15

Up Front

2024-8-15

Genetic relations between type 1 diabetes, coronary artery disease and leukocyte counts

2024-8-14

Elevations in plasma glucagon are associated with reduced insulin clearance after ingestion of a mixed-macronutrient meal in people with and without type 2 diabetes

2024-8-13

Ageing well with diabetes: the role of technology

2024-8-13

Accuracy of continuous glucose monitoring in the hospital setting: an observational study

2024-8-10

Cardiovascular autonomic neuropathy in diabetes: an update with a focus on management

2024-8-9

Diabetes technology in people with diabetes and advanced chronic kidney disease

2024-8-8

Mortality risk for kidney transplant candidates with diabetes: a population cohort study

2024-8-6

Whole-exome and whole-genome sequencing of 1064 individuals with type 1 diabetes reveals novel genes for diabetic kidney disease

2024-8-6

Identification of type 1 diabetes risk phenotypes using an outcome-guided clustering analysis

2024-8-6

Association of glucagon-like peptide-1 receptor agonists with suicidal ideation and self-injury in individuals with diabetes and obesity: a propensity-weighted, population-based cohort study

2024-8-6

Scientists and scientific journals should adhere to ethical standards for the use and reporting of data from Indigenous people

2024-8-5

Insulin sensitivity, disposition index and insulin clearance in cystic fibrosis: a cross-sectional study

2024-8-2

Analysis of early-pregnancy metabolome in early- and late-onset gestational diabetes reveals distinct associations with maternal overweight

2024-7-31

The impact of hypoglycaemia on daily functioning among adults with diabetes: a prospective observational study using the Hypo-METRICS app

2024-7-30

Deletion of RFX6 impairs iPSC-derived islet organoid development and survival, with no impact on PDX1+/NKX6.1+ progenitors

2024-7-30

Longitudinal metabolite and protein trajectories prior to diabetes mellitus diagnosis in Danish blood donors: a nested case–control study

2024-7-30

Perceived glucose levels matter more than CGM-based data in predicting diabetes distress in type 1 or type 2 diabetes: a precision mental health approach using n-of-1 analyses

2024-7-30

Effects of semaglutide, empagliflozin and their combination on renal diffusion-weighted MRI and total kidney volume in patients with type 2 diabetes: a post hoc analysis from a 32 week randomised trial

2024-7-30

Assessing the influence of insulin type (ultra-rapid vs rapid insulin) and exercise timing on postprandial exercise-induced hypoglycaemia risk in individuals with type 1 diabetes: a randomised controlled trial

2024-7-29

Postprandial fatty acid-binding protein 4 is associated with muscle insulin resistance

2024-7-26